Dear members, I am delighted to launch the Pharmacovigilance (PV) section in this journal issue! Those of you who have been around for a while may know that, in the past, PV-related articles were published either as feature articles or as guest topics in the Communication section (and with this, I would like to thank Lisa Chamberlain James for making this possible over the past six years!)